Tus kws kho mob
QP64R1-20 Medical Drug Update for New to Market Viltolarsen (Viltepso)
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2761 - 2770 ntawm 3600
Tus kws kho mob
QP80-20 MHCP Pharmacy Benefit Update - AvsolaTM, Ilaris® and PerserisTM
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP78-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa®
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP77-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
QP82-20 Commercial Pharmacy Benefit Exclusion for Amzeeq™ (minocycline) foam, brimonidine ophthalmic solution 0.15% and ProAir® (albuterol sulfate) HFA
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tus kws kho mob
2020 September Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 19, 2020
Tus kws kho mob
QP76-20 Outlier Outpatient Therapy Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020